U.S. markets close in 1 hour 40 minutes

Novamind Inc. (NM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.64000.0000 (0.00%)
As of 2:02PM EDT. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6400
Open0.6400
Bid0.6400 x N/A
Ask0.6700 x N/A
Day's Range0.6400 - 0.6400
52 Week Range0.5900 - 2.3400
Volume7,674
Avg. Volume33,560
Market Cap26.578M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • ACCESSWIRE

      Novamind Announces DTC Eligibility for its Common Shares

      TORONTO, ON / ACCESSWIRE / September 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the U.

    • ACCESSWIRE

      Novamind to Present at Benzinga Healthcare Conference

      Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcareTORONTO, ON / ACCESSWIRE / September 23, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will participate in the Benzinga Healthcare Small Cap Conference taking place virtually on September 29-30, 2021.

    • ACCESSWIRE

      Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF

      TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has been included in the AdvisorShares Psychedelics ETF trading on the NYSE under the ticker "PSIL" (the "ETF").